The levels of renin-angiotensin related components are modified in the hippocampus of rats submitted to pilocarpine model of epilepsy

Neurochemistry International

Volumn 61, Issue 1, 2012, Pages 54-62

  Gouveia, Telma Luciana Furtado ^a   Frangiotti, Maria Isabel Berzaghi ^a   De Brito, Joíse Marques Vieira ^a   De Castro Neto, Eduardo Ferreira ^a   Sakata, Maisa Mayume ^a   Febba, Andreia Cristina ^a   Casarini, Dulce Elena ^a   Amado, Débora ^a   Cavalheiro, Esper Abrão ^a   Almeida, Sandro Soares ^a   Manchini, Martha Trindade ^b   Araújo, Ronaldo Carvalho ^a   Silva Jr , José Antonio ^b   Da Graça Naffah Mazzacoratti, Maria ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDADE NOVE DE JULHO   (Brazil)

Author keywords

Angiotensin converting enzyme (ACE); Angiotensin I; Angiotensin II; Pilocarpine; Temporal lobe epilepsy

Indexed keywords

ANGIOTENSIN DERIVATIVE; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN II [3-8]; ANGIOTENSIN III; ANGIOTENSIN V; ANGIOTENSIN VI; ANGIOTENSIN VII; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; MEMBRANE METALLOENDOPEPTIDASE; PILOCARPINE; RENIN; TONIN; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; EPILEPSY; EPILEPTOGENESIS; HIPPOCAMPUS; HORMONE BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; EPILEPSY, TEMPORAL LOBE; HIPPOCAMPUS; MALE; PILOCARPINE; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RENIN-ANGIOTENSIN SYSTEM;

RATTUS; RATTUS NORVEGICUS;

EID: 84861373540     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2012.04.012     Document Type: Article

References (52)

1. N. Alenina, P. Xu, B. Rentzsch, E.L. Patkin, and M. Bader Genetically altered animal models for Mas and angiotensin-(1-7) Exp. Physiol. 93 5 2008 528 537
2. R.C. Araujo, M.P. Lima, E.S. Lomez, M. Bader, J.B. Pesquero, M. Sumitani, and J.L. Pesquero Tonin expression in the rat brain and tonin-mediated central production of angiotensin II Physiol. Behav. 76 2 2002 327 333
3. G. Arganaraz, S. Regina Perosa, E. Cristina Lencioni, M. Bader, E. Abrao Cavalheiro, M. da Graca Naffah-Mazzacoratti, J.B. Pesquero, and J. Antonio Silva Jr. Role of kinin B1 and B2 receptors in the development of pilocarpine model of epilepsy Brain Res. 1013 1 2004 30 39
4. G.A. Arganaraz, J.A. Silva Jr., S.R. Perosa, L.G. Pessoa, F.F. Carvalho, J.L. Bascands, M. Bader, E. da Silva Trindade, D. Amado, E.A. Cavalheiro, J.B. Pesquero, and M. da Graca Naffah-Mazzacoratti The synthesis and distribution of the kinin B1 and B2 receptors are modified in the hippocampus of rats submitted to pilocarpine model of epilepsy Brain Res. 1006 1 2004 114 125
5. G.A. Arganaraz, A.C. Konno, S.R. Perosa, J.F. Santiago, M.A. Boim, D.B. Vidotti, P.P. Varella, L.G. Costa, M. Canzian, M.A. Porcionatto, E.M. Yacubian, A.C. Sakamoto, H. Carrete Jr., R.S. Centeno, D. Amado, E.A. Cavalheiro, J.A. Junior, and G. Mazzacoratti Mda The renin-angiotensin system is upregulated in the cortex and hippocampus of patients with temporal lobe epilepsy related to mesial temporal sclerosis Epilepsia 49 8 2008 1348 1357
6. D.L. Armstrong, E.A. Garcia, T. Ma, B. Quinones, and M.J. Wayner Angiotensin II blockade of long-term potentiation at the perforant path-granule cell synapse in vitro Peptides 17 4 1996 689 693
7. N.M. Barnes, C.H. Cheng, B. Costall, R.J. Naylor, T.J. Williams, and C.M. Wischik Angiotensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's disease Eur. J. Pharmacol. 200 2-3 1991 289 292
8. Y. Ben-Ari, E. Tremblay, D. Riche, G. Ghilini, and R. Naquet Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline or pentetrazole: metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy Neuroscience 6 7 1981 1361 1391
9. J. Benicky, E. Sánchez-Lemus, M. Honda, T. Pang, M. Orecna, J. Wang, Y. Leng, D.M. Chuang, and J.M. Saavedra Angiotensin II AT1 receptor blockade ameliorates brain inflammation Neuropsychopharmacology 36 4 2011 857 870
10. E.D. Bird Chemical pathology of Huntington's disease Annu. Rev. Pharmacol. Toxicol. 20 1980 533 551
11. J.C. Borges, J.A. Silva Jr., M.A. Gomes, E.S. Lomez, K.M. Leite, R.C. Araujo, M. Bader, J.B. Pesquero, and J.L. Pesquero Tonin in rat heart with experimental hypertrophy Am. J. Physiol. Heart Circ. Physiol. 284 6 2003 H2263 H2268
12. E.A. Cavalheiro, J.P. Leite, Z.A. Bortolotto, W.A. Turski, C. Ikonomidou, and L. Turski Long-term effects of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneous recurrent seizures Epilepsia 32 6 1991 778 782
13. L.I. Chen, O.M. Prakash, and R.N. Re The interaction of insulin and angiotensin II on the regulation of human neuroblastoma cell growth Mol. Chem. Neuropathol. 18 1-2 1993 189 196
14. M.J. Daemen, D.M. Lombardi, F.T. Bosman, and S.M. Schwartz Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall Circ. Res. 68 2 1991 450 456
15. L. Danielyan, R. Klein, L.R. Hanson, M. Buadze, M. Schwab, C.H. Gleiter, and W.H. Frey Protective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer disease Rejuvenation Res. 13 2-3 2010 195 201
16. M. de Gasparo, K.J. Catt, T. Inagami, J.W. Wright, and T. Unger International union of pharmacology. XXIII. The angiotensin II receptors Pharmacol. Rev. 52 3 2000 415 472
17. J.B. Denny, J. Polan-Curtain, M.J. Wayner, and D.L. Armstrong Angiotensin II blocks hippocampal long-term potentiation Brain Res. 567 2 1991 321 324
18. C.F. Deschepper, J. Bouhnik, and W.F. Ganong Colocalization of angiotensinogen and glial fibrillary acidic protein in astrocytes in rat brain Brain Res. 374 1 1986 195 198
19. L. Ferder, F. Inserra, and M. Martinez-Maldonado Inflammation and the metabolic syndrome: role of angiotensin II and oxidative stress Curr. Hypertens. Rep. 8 3 2006 191 198
20. L.F. Ferder, F. Inserra, and N. Basso Effects of renin-angiotensin system blockade in the aging kidney Exp. Gerontol. 38 3 2003 237 244
21. C.M. Ferrario Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research J. Renin-Angiotensin Aldosterone Syst. 7 1 2006 3 14
22. T.L. Gouveia, F.A. Scorza, M.J. Silva, A. Bandeira Tde, S.R. Perosa, G.A. Arganaraz, P. Silva Mde, T.R. Araujo, M.I. Frangiotti, D. Amado, E.A. Cavalheiro, J.A. Silva Jr., and G. Naffah-Mazzacoratti Mda Lovastatin decreases the synthesis of inflammatory mediators in the hippocampus and blocks the hyperthermia of rats submitted to long-lasting status epilepticus Epilepsy Behav. 20 1 2011 1 5
23. T.N. Grammatopoulos, F. Ahmadi, S.M. Jones, M.W. Fariss, J.A. Weyhenmeyer, and W.M. Zawada Angiotensin II protects cultured midbrain dopaminergic neurons against rotenone-induced cell death Brain Res. 1045 1-2 2005 64 71
24. G. Jing, T. Grammatopoulos, P. Ferguson, W. Schelman, and J. Weyhenmeyer Inhibitory effects of angiotensin on NMDA-induced cytotoxicity in primary neuronal cultures Brain Res Bull. 62 5 2004 397 403
25. V.T. Karamyan, and R.C. Speth Identification of a novel non-AT1, non-AT2 angiotensin binding site in the rat brain Brain Res. 1143 2007 83 91
26. E. Kostenis, G. Milligan, A. Christopoulos, C.F. Sanchez-Ferrer, S. Heringer-Walther, P.M. Sexton, F. Gembardt, E. Kellett, L. Martini, P. Vanderheyden, H.P. Schultheiss, and T. Walther G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor Circulation 111 14 2005 1806 1813
27. T.L. Lazaroni, A.C. Raslan, W.R. Fontes, M.L. de Oliveira, M. Bader, N. Alenina, M.F. Moraes, R.A. Dos Santos, and G.S. Pereira Angiotensin-(1-7)/Mas axis integrity is required for the expression of object recognition memory Neurobiol. Learn Mem. 97 1 2012 113 123
28. A. Lippoldt, M. Paul, K. Fuxe, and D. Ganten The brain renin-angiotensin system: molecular mechanisms of cell to cell interactions Clin. Exp. Hypertens. 17 1-2 1995 251 266
29. K.A. Martin, and S. Hockfield Expression of the mas proto-oncogene in the rat hippocampal formation is regulated by neuronal activity Brain. Res. Mol. Brain Res. 19 4 1993 303 309
30. J.O. McNamara Cellular and molecular basis of epilepsy J. Neurosci. 14 6 1994 3413 3425
31. S. Meffert, M. Stoll, U.M. Steckelings, S.P. Bottari, and T. Unger The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cells Mol. Cell Endocrinol. 122 1 1996 59 67
32. M.G. Naffah-Mazzacoratti, M.I. Bellissimo, and E.A. Cavalheiro Profile of prostaglandin levels in the rat hippocampus in pilocarpine model of epilepsy Neurochem. Int. 27 6 1995 461 466
33. M.G. Pereira, C. Becari, J.A. Oliveira, M.C. Salgado, N. Garcia-Cairasco, and C.M. Costa-Neto Inhibition of the renin-angiotensin system prevents seizures in a rat model of epilepsy Clin. Sci. (Lond.) 119 11 2010 477 482
34. S.R. Perosa, G.A. Arganaraz, E.M. Goto, L.G. Costa, A.C. Konno, P.P. Varella, J.F. Santiago, J.B. Pesquero, M. Canzian, D. Amado, E.M. Yacubian, H. Carrete Jr., R.S. Centeno, E.A. Cavalheiro, J.A. Silva Jr., and G. Mazzacoratti Mda Kinin B1 and B2 receptors are overexpressed in the hippocampus of humans with temporal lobe epilepsy Hippocampus 17 1 2007 26 33
35. A. Pitkanen, and T.P. Sutula Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy Lancet Neurol. 1 3 2002 173 181
36. F.A. Ronchi, M.C. Irigoyen, and D.E. Casarini Association of somatic and N-domain angiotensin-converting enzymes from Wistar rat tissue with renal dysfunction in diabetes mellitus J. Renin-Angiotensin Aldosterone Syst. 8 1 2007 34 41
37. J.M. Saavedra, H. Ando, I. Armando, G. Baiardi, C. Bregonzio, A. Juorio, and M. Macova Anti-stress and anti-anxiety effects of centrally acting angiotensin II AT1 receptor antagonists Regul. Pept. 128 3 2005 227 238
38. R.O. Sampaio, M. Grinberg, J.J. Leite, F. Tarasoutchi, W.A. Chalela, M. Izaki, G.S. Spina, E.G. Rossi, and C. Mady Effect of enalapril on left ventricular diameters and exercise capacity in asymptomatic or mildly symptomatic patients with regurgitation secondary to mitral valve prolapse or rheumatic heart disease Am. J. Cardiol. 96 1 2005 117 121
39. R.A.S. Santos, A.C. Simoes e Silva, C. Maric, D.M.R. Silva, R.P. Machado, I. De Buhr, S. Heringer-Walther, S.V.B. Pinheiro, M.T. Lopes, M. Bader, E.P. Mendes, V.S. Lemos, M.J. Campagnole-Santos, H.-P. Schultheiss, R. Speth, and T. Walther Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas Proc. Nat. Acad. Sci. U.S.A. 100 14 2003 8258 8263
40. W.R. Schelman, J.L. Kurth, R.L. Berdeaux, S.W. Norby, and J.A. Weyhenmeyer Angiotensin II type-2 (AT2) receptor-mediated inhibition of NMDA receptor signalling in neuronal cells Brain Res. Mol. Brain Res. 48 2 1997 197 205
41. W.R. Schelman, R. Andres, P. Ferguson, B. Orr, E. Kang, and J.A. Weyhenmeyer Angiotensin II attenuates NMDA receptor-mediated neuronal cell death and prevents the associated reduction in Bcl-2 expression Brain Res. Mol. Brain Res. 128 1 2004 20 29
42. J.A. Silva Jr, E.M. Goto, S.R. Perosa, G.A. Argañaraz, E.A. Cavalheiro, M.G. Naffah-Mazzacoratti, and J.B. Pesquero Kinin B1 receptors facilitate the development of temporal lobe epilepsy in mice Int. Immunopharmacol. 8 2 2008 197 199
43. K.D. Silveira, F.M. Coelho, A.T. Vieira, D. Sachs, L.C. Barroso, V.V. Costa, T.L. Bretas, M. Bader, L.P. de Sousa, T.A. da Silva, R.A. dos Santos, A.C. Simoes e Silva, and M.M. Teixeira Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis J. Immunol. 185 9 2010 5569 5576
44. W.B. Strawn, C.M. Ferrario, and E.A. Tallant Angiotensin-(1-7) reduces smooth muscle growth after vascular injury Hypertension 33 1 Pt 2 1999 207 211
45. E.A. Tallant, C.M. Ferrario, and P.E. Gallagher Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor Am. J. Physiol. Heart Circ. Physiol. 289 4 2005 H1560 H1566
46. J. Tian, J. Shi, K. Bailey, J.M. Harris, A. Pritchard, J.C. Lambert, M.C. Chartier-Harlin, S.M. Pickering-Brown, C.L. Lendon, and D.M. Mann A polymorphism in the angiotensin 1-converting enzyme gene is associated with damage to cerebral cortical white matter in Alzheimer's disease Neurosci. Lett. 354 2 2004 103 106
47. W.A. Turski, E.A. Cavalheiro, M. Schwarz, S.J. Czuczwar, Z. Kleinrok, and L. Turski Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study Behav. Brain Res. 9 3 1983 315 335
48. P.P. Varella, J.F. Santiago, H. Carrete Jr., E.M. Higa, E.M. Yacubian, R.S. Centeno, L.O. Caboclo, E.F. Castro Neto, M. Canzian, D. Amado, E.A. Cavalheiro, and G. Naffah-Mazzacoratti Mda Relationship between fluid-attenuated inversion-recovery (FLAIR) signal intensity and inflammatory mediator's levels in the hippocampus of patients with temporal lobe epilepsy and mesial temporal sclerosis Arq. Neuropsiquiatr. 69 1 2011 91 99
49. A. Vezzani, and T. Granata Brain inflammation in epilepsy: experimental and clinical evidence Epilepsia 46 11 2005 1724 1743
50. J.W. Wright, and J.W. Harding The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning, and memory Prog. Neurobiol. 72 4 2004 263 293
51. J.W. Wright, J.R. Reichert, C.J. Davis, and J.W. Harding Neural plasticity and the brain renin-angiotensin system Neurosci. Biobehav. Rev. 26 5 2002 529 552
52. T. Yamada, M. Horiuchi, and V.J. Dzau Angiotensin II type 2 receptor mediates programmed cell death Proc. Natl. Acad. Sci. USA 93 1 1996 156 160